Thermo Fisher Scientific (MEX:TMO) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TMO Thermo Fisher Scientific Inc MEX:TMO
72 GF Score
Price MXN11,320.00
GF Value MXN10,216.62
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Thermo Fisher Scientific Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Thermo Fisher Scientific  (MEX:TMO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Thermo Fisher Scientific Cyclically Adjusted PS Ratio Related Terms


Thermo Fisher Scientific Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Thermo Fisher Scientific's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Cyclically Adjusted PS Ratio Chart

Thermo Fisher Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.25 7.93 5.89 6.29 5.53

Thermo Fisher Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 4.52 5.49 4.46 4.35

MEX:TMO vs DHR, NTRA, IDXX: Cyclically Adjusted PS Ratio Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Cyclically Adjusted PS Ratio falls into.


MEX:TMO
72GF Score
Thermo Fisher Scientific Inc MEX:TMO
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Thermo Fisher Scientific Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Thermo Fisher Scientific's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Thermo Fisher Scientific's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=562.367/333.9520*333.9520
=562.367

Current CPI (Jun. 2026) = 333.9520.

Thermo Fisher Scientific Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 211.962 241.428 293.194
201612 247.552 241.432 342.417
201703 245.471 243.801 336.240
201706 235.535 244.955 321.110
201709 228.082 246.819 308.600
201712 283.034 246.524 383.410
201803 270.027 249.554 361.349
201806 290.495 251.989 384.983
201809 276.768 252.439 366.137
201812 318.498 251.233 423.364
201903 291.842 254.202 383.401
201906 299.766 256.143 390.826
201909 301.665 256.759 392.359
201912 327.061 256.974 425.034
202003 312.207 258.115 403.937
202006 405.420 257.797 525.184
202009 472.059 260.280 605.675
202012 542.165 260.474 695.106
202103 507.947 264.877 640.410
202106 468.873 271.696 576.310
202109 470.740 274.310 573.091
202112 558.162 278.802 668.572
202203 613.503 287.504 712.618
202206 558.293 296.311 629.214
202209 547.201 296.808 615.680
202212 573.626 296.797 645.436
202303 514.990 301.836 569.786
202306 487.506 305.109 533.592
202309 465.077 307.789 504.610
202312 492.779 306.746 536.485
202403 457.789 312.332 489.478
202406 474.552 314.175 504.425
202409 522.443 315.301 553.347
202412 597.885 315.605 632.642
202503 558.122 319.799 582.822
202506 560.726 322.561 580.528
202509 548.225 324.800 563.673
202512 593.013 324.054 611.126
202603 518.090 330.213 523.956
202606 562.367 333.952 562.367

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Thermo Fisher Scientific (MEX:TMO) Overvalued in 2026?

Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be overvalued. The current stock price of MXN11,320.00 is trading 10.8% above its estimated GF Value™ of MXN10,216.62. GuruFocus considers Thermo Fisher Scientific to be Modestly Overvalued.

Key valuation signals for MEX:TMO:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: MXN10,216.62 vs. price of MXN11,320.00 (10.8% above fair value)
  • GF Score™: 72/100 with 10 warning signs

No single metric tells the full story. See the MEX:TMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Thermo Fisher Scientific Business Description

Address 168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
72GF Score

Get the complete analysis for MEX:TMO

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN11,320.00
Price
MXN10,216.62
GF Value